Sirtuin Functions in Female Fertility: Possible Role in Oxidative Stress and Aging

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Tatone, Carla ^a,b   Di Emidio, Giovanna ^a   Vitti, Maurizio ^a   Di Carlo, Michela ^a   Santini, Silvano ^a   D'Alessandro, Anna Maria ^a   Falone, Stefano ^a   Amicarelli, Fernanda ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE; MEDICINE;

ADP-RIBOSYLTRANSFERASE; ANTI-AGING; DEACETYLASE; FEMALE FERTILITY; FUTURE STRATEGY; GRANULOSA CELLS; REDOX STATE; RESEARCH PAPERS;

CELL CULTURE;

NATURAL PRODUCT; SIRTUIN; SIRTUIN 1;

AGING; EMBRYO; ENERGY METABOLISM; FEMALE FERTILITY; GRANULOSA CELL; HUMAN; NONHUMAN; OOCYTE; OVARY FUNCTION; OXIDATIVE STRESS; PROTEIN FUNCTION; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; FEMALE; FERTILITY; METABOLISM; OVARY; PHYSIOLOGY;

AGING; ANIMALS; ENERGY METABOLISM; FEMALE; FERTILITY; HUMANS; OVARY; OXIDATIVE STRESS; SIRTUINS;

EID: 84929646351     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/659687     Document Type: Review

References (116)

1. E. R. Te Velde and P. L. Pearson, "The variability of female reproductive ageing," Human Reproduction Update, vol. 8, no. 2, pp. 141-154, 2002.
2. A. A. Cohen, "Female post-reproductive lifespan: a general mammalian trait," Biological Reviews of the Cambridge Philosophical Society, vol. 79, no. 4, pp. 733-750, 2004.
3. S. Luo and C. T. Murphy, "Caenorhabditis elegans reproductive aging: regulation and underlying mechanisms," Genesis, vol. 49, no. 2, pp. 53-65, 2011.
4. D. T. Baird, J. Collins, J. Egozcue et al., "Fertility and ageing,"Human Reproduction Update, vol. 11, no. 3, pp. 261-276, 2005.
5. P. Hamet and J. Tremblay, "Genes of aging," Metabolism: Clinical and Experimental, vol. 52, no. 10, supplement 2, pp. 5-9, 2003.
6. Q. Li, X. Geng, W. Zheng, J. Tang, B. Xu, and Q. Shi, "Current understanding of ovarian aging," Science China Life Sciences, vol. 55, no. 8, pp. 659-669, 2012.
7. D. R. Meldrum, "Aging gonads, glands, and gametes: immutable or partially reversible changes?" Fertility and Sterility, vol. 99, no. 1, pp. 1-4, 2013.
8. C. Tatone and F. Amicarelli, "The aging ovary - the poor granulosa cells," Fertility and Sterility, vol. 99, no. 1, pp. 12-17, 2013.
9. C. Tatone, U. Eichenlaub-Ritter, and F. Amicarelli, "Dicarbonyl stress and glyoxalases in ovarian function," Biochemical Society Transactions, vol. 42, no. 2, pp. 433-438, 2014.
10. S. Michan and D. Sinclair, "Sirtuins in mammals: insights into their biological function," Biochemical Journal, vol. 404, no. 1, pp. 1-13, 2007.
11. B. J. Morris, "Seven sirtuins for seven deadly diseases of aging,"Free Radical Biology and Medicine, vol. 56, pp. 133-171, 2013.
12. P. Monget, J. Bobe, A. Gougeon, S. Fabre, D. Monniaux, and R. Dalbies-Tran, "The ovarian reserve in mammals: a functional and evolutionary perspective," Molecular and Cellular Endocrinology, vol. 356, no. 1-2, pp. 2-12, 2012.
13. J. Craig, M. Orisaka, H. Wang et al., "Gonadotropinandintraovarian signals regulating follicle development and atresia: the delicate balance between life and death," Frontiers in Bioscience, vol.12, no. 10, pp. 3628-3639, 2007.
14. L. K. McGinnis, S. D. Limback, and D. F. Albertini, "Signaling modalities during oogenesis in mammals," Current Topics in Developmental Biology, vol. 102, pp. 227-242, 2013.
15. A. P. Sobinoff, J. M. Sutherland, and E. A. Mclaughlin, "Intra signalling during female gametogenesis," Molecular Human Reproduction, vol. 19, no. 5, pp. 265-278, 2013.
16. M. Zuccotti, V. Merico, S. Cecconi, C. A. Redi, and S. Garagna, "What does it take to make a developmentally competent mammalian egg?" Human Reproduction Update, vol. 17, no. 4, Article ID dmr009, pp. 525-540, 2011.
17. P. Bhattacharya and A. F. Keating, "Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity," Toxicology and Applied Pharmacology, vol. 261, no. 3, pp. 227-235, 2012.
18. M. J. Faddy, R. G. Gosden, A. Gougeon, S. J. Richardson, and J. F. Nelson, "Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause," Human Reproduction, vol. 7, no. 10, pp. 1342-1346, 1992.
19. U. Eichenlaub-Ritter, "Oocyte ageing and its cellular basis,"International Journal of Developmental Biology, vol.56, no. 10-12, pp. 841-852, 2012.
20. M. V. Sauer, R. J. Paulson, and R. A. Lobo, "A preliminary report on oocyte donation extending reproductive potential to women over 40," The New England Journal of Medicine, vol. 323, no. 17, pp. 1157-1160, 1990.
21. C. Tatone, F. Amicarelli, M. C. Carbone et al., "Cellular and molecular aspects of ovarian follicle ageing," Human Reproduction Update, vol. 14, no. 2, pp. 131-142, 2008.
22. D. Harman, "Aging: a theory based on free radical and radiation chemistry," The Journals of Gerontology, vol. 11, no. 3, pp. 298-300, 1956.
23. R. Buffenstein, Y. H. Edrey, T. Yang, and J. Mele, "The oxidative stress theory of aging: embattled or invincible? Insights from non-traditional model organisms," Age, vol. 30, no. 2-3, pp. 99-109, 2008.
24. J. J. Tarin, "Aetiology of age-associated aneuploidy: a mechanism based on the "free radical theory of ageing"," Human Reproduction, vol. 10, no. 6, pp. 1563-1565, 1995.
25. A. Agarwal, S. Gupta, and R. K. Sharma, "Role of oxidative stress in female reproduction," Reproductive Biology and Endocrinology, vol. 3, article 28, 2005.
26. M. Benkhalifa, Y. J. Ferreira, H. Chahine et al., "Mitochondria: participation to infertility as source of energy and cause of senescence," International Journal of Biochemistry & Cell Biology, vol. 55, pp. 60-64, 2014.
27. T. Ishii, M. Miyazawa, Y. Takanashi et al., "Genetically induced oxidative stress in mice causes thrombocytosis, splenomegaly and placental angiodysplasia that leads to recurrent abortion,"Redox Biology, vol. 2, pp. 679-685, 2014.
28. M. Szafarowska and M. Jerzak, "Ovarian aging and infertility,"Ginekologia Polska, vol. 84, no. 4, pp. 298-304, 2013.
29. J. Lim and U. Luderer, "Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary,"Biology of Reproduction, vol. 84, no. 4, pp. 775-782, 2011.
30. M. Ito, M. Muraki, Y. Takahashi et al., "Glutathione S-transferase theta 1 expressed in granulosa cells as a biomarker for oocyte quality in age-related infertility," Fertility and Sterility, vol. 90, no. 4, pp. 1026-1035, 2008.
31. M. Ito, M. Imai, M. Muraki et al., "GSTT1 is upregulated by oxidative stress through p38-mk2 signaling pathway in human granulosa cells: Possible association with mitochondrial activity,"Aging, vol. 3, no. 12, pp. 1213-1223, 2011.
32. L. Matos, D. Stevenson, F. Gomes, J. L. Silva-carvalho, and H. Almeida, "Superoxide dismutase expression in human cumulus oophorus cells," Molecular Human Reproduction, vol. 15, no. 7, pp. 411-419, 2009.
33. E. H. Ruder, T. J. Hartman, R. H. Reindollar, and M. B. Goldman, "Female dietary antioxidant intake and time to pregnancy among couples treated for unexplained infertility," Fertility and Sterility, vol. 101, no. 3, pp. 759-766, 2014.
34. W. Mair and A. Dillin, "Aging and survival: the genetics of life span extension by dietary restriction," Annual Review of Biochemistry, vol. 77, pp. 727-754, 2008.
35. S. Alavez, M. C. Vantipalli, D. J. S. Zucker, I. M. Klang, and G. J. Lithgow, "Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan," Nature, vol. 472, no. 7342, pp. 226-230, 2011.
36. V. Calabrese, C. Cornelius, A. T. Dinkova-Kostova, E. J. Calabrese, and M. P. Mattson, "Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders," Antioxidants and Redox Signaling, vol. 13, no. 11, pp. 1763-1811, 2010.
37. E. Verdin, "The many faces of sirtuins: coupling of NAD metabolism, sirtuins and lifespan," Nature Medicine, vol. 20, no. 1, pp. 25-27, 2014.
38. H. Yang, T. Yang, J. A. Baur et al., "Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival," Cell, vol. 130, no. 6, pp. 1095-1107, 2007.
39. R. H. Houtkooper, C. Cantó, R. J. Wanders, and J. Auwerx, "The secret life of NAD+ : an old metabolite controlling new metabolic signaling pathways," Endocrine Reviews, vol. 31, no. 2, pp. 194-223, 2010.
40. C. Cantó and J. Auwerx, "Targeting sirtuin 1 to improve metabolism: all you need is NAD+ ?" Pharmacological Reviews, vol. 64, no. 1, pp. 166-187, 2012.
41. D. Shore, M. Squire, and K. A. Nasmyth, "Characterization of two genes required for the position-effect control of yeast mating-type genes," The EMBO Journal, vol. 3, no. 12, pp. 2817-2823, 1984.
42. J. S. Smith, C. B. Brachmann, I. Celic et al., "A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6658-6663, 2000.
43. B. J. North and E. Verdin, "Sirtuins: Sir2-related NAD-dependent protein deacetylases," Genome Biology, vol. 5, no. 5, article 224, 2004.
44. B. Pucci, L. Villanova, L. Sansone et al., "Sirtuins: the molecular basis of beneficial effects of physical activity," Internal and Emergency Medicine, vol. 8, no. 1, pp. 23-25, 2013.
45. M. N. Sack and T. Finkel, "Mitochondrial metabolism, sirtuins, and aging," Cold Spring Harbor Perspectives in Biology, vol. 4, no. 12, Article ID a013102, 2012.
46. S.-I. Imai and L. Guarente, "Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases," Trends in Pharmacological Sciences, vol. 31, no. 5, pp. 212-220, 2010.
47. T. Finkel, C.-X. Deng, and R. Mostoslavsky, "Recent progress in the biology and physiology of sirtuins," Nature, vol. 460, no. 7255, pp. 587-591, 2009.
48. P. Oberdoerffer, S. Michan, M. McVay et al., "SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging," Cell, vol. 135, no. 5, pp. 907-918, 2008.
49. A. Furukawa, S. Tada-Oikawa, and S. Kawanishi, "H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion," Cellular Physiology and Biochemistry, vol. 20, no. 1-4, pp. 45-54, 2007.
50. W. He, Y. Wang, M.-Z. Zhang et al., "Sirt1 activation protects the mouse renal medulla from oxidative injury," Journal of Clinical Investigation, vol. 120, no. 4, pp. 1056-1068, 2010.
51. C.-L. Kao, L.-K. Chen, Y.-L. Chang et al., "Resveratrol protects human endothelium from H2O2-induced oxidative stress and senescence via SirT1 activation," Journal of Atherosclerosis and Thrombosis, vol. 17, no. 9, pp. 970-979, 2010.
52. H. Fan, H.-C. Yang, L. You, Y.-Y. Wang, W.-J. He, and C.-M. Hao, "The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury," Kidney International, vol. 83, no. 3, pp. 404-413, 2013.
53. A. Brunet, L. B. Sweeney, J. F. Sturgill et al., "Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase,"Science, vol. 303, no. 5666, pp. 2011-2015, 2004.
54. A. van der Horst, L. G. J. Tertoolen, L. M. M. de Vries-Smits, R. A. Frye, R. H. Medema, and B. M. T. Burgering, "FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2SIRT1," The Journal of Biological Chemistry, vol. 279, no. 28, pp. 28873-28879, 2004.
55. Y. Kobayashi, Y. Furukawa-Hibi, C. Chen et al., "SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress," International Journal of Molecular Medicine, vol. 16, no. 2, pp. 237-243, 2005.
56. K. Hasegawa, S. Wakino, K. Yoshioka et al., "Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression," Biochemical and Biophysical Research Communications, vol. 372, no. 1, pp. 51-56, 2008.
57. L. Zhang, S. Huang, Y. Chen, Z. Wang, E. Li, and Y. Xu, "Icariin inhibits hydrogen peroxide-mediated cytotoxicity by up-regulating sirtuin type 1-dependent catalase and peroxiredoxin,"Basic and Clinical Pharmacology and Toxicology, vol. 107, no. 5, pp. 899-905, 2010.
58. P. S. Pardo, J. S. Mohamed, M. A. Lopez, and A. M. Boriek, "Induction of Sirt1 by mechanical stretch of skeletal muscle through the early response factor EGR1 triggers an antioxidative response," Journal of Biological Chemistry, vol. 286, no. 4, pp. 2559-2566, 2011.
59. Y. S. Hori, A. Kuno, R. Hosoda, and Y. Horio, "Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress,"PLoS ONE, vol. 8, no. 9, Article ID e73875, 2013.
60. Y. Cheng, H. Takeuchi, Y. Sonobe et al., "Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes," Journal of Neuroimmunology, vol. 269, no. 1-2, pp. 38-43, 2014.
61. S. Nemoto, M. M. Fergusson, and T. Finkel, "SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α," Journal of Biological Chemistry, vol. 280, no. 16, pp. 16456-16460, 2005.
62. H. Liang and W. F. Ward, "PGC-1α: a key regulator of energy metabolism," American Journal of Physiology: Advances in Physiology Education, vol. 30, no. 4, pp. 145-151, 2006.
63. Z. Gerhart-Hines, J. T. Rodgers, O. Bare et al., "Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α," The EMBO Journal, vol. 26, no. 7, pp. 1913-1923, 2007.
64. L. Zhong and R. Mostoslavsky, "Fine tuning our cellular factories: sirtuins in mitochondrial biology," Cell Metabolism, vol. 13, no. 6, pp. 621-626, 2011.
65. K. N. Schmidt, P. Amstad, P. Cerutti, and P. A. Baeuerle, "The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB," Chemistry and Biology, vol. 2, no. 1, pp. 13-22,1995.
66. F. Yeung, J. E. Hoberg, C. S. Ramsey et al., "Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase," EMBO Journal, vol. 23, no. 12, pp. 2369-2380, 2004.
67. A. Kauppinen, T. Suuronen, J. Ojala, K. Kaarniranta, and A. Salminen, "Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders,"Cellular Signalling, vol. 25, no. 10, pp. 1939-1948, 2013.
68. H.-F. Yuan, C. Zhai, X.-L. Yan et al., "SIRT1 is required for long-term growth of human mesenchymal stem cells," Journal of Molecular Medicine, vol. 90, no. 4, pp. 389-400, 2012.
69. Y. Zu, L. Liu, M. Y. K. Lee et al., "SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells," Circulation Research, vol. 106, no. 8, pp. 1384-1393, 2010.
70. S. Yamashita, K. Ogawa, T. Ikei, M. Udono, T. Fujiki, and Y. Katakura, "SIRT1 prevents replicative senescence of normal human umbilical cord fibroblast through potentiating the transcription of human telomerase reverse transcriptase gene,"Biochemical and Biophysical Research Communications, vol. 417, no. 1, pp. 630-634, 2012.
71. D. Xu, F. Takeshita, Y. Hino et al., "miR-22 represses cancer progression by inducing cellular senescence," Journal of Cell Biology, vol. 193, no. 2, pp. 409-424, 2011.
72. M. Yamakuchi, "MicroRNA regulation of SIRT1," Frontiers in Physiology, vol. 3,article68, 2012.
73. Z. Chen, T.-P. Shentu, L. Wen, D. A. Johnson, and J. Y.-J. Shyy, "Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium," Antioxidants and Redox Signaling, vol. 19, no. 13, pp. 1522-1538, 2013.
74. J. R. Revollo and X. Li, "The ways and means that fine tune Sirt1 activity," Trends in Biochemical Sciences, vol. 38, no. 3, pp. 160-167, 2013.
75. O. Marton, E. Koltai, C. Nyakas et al., "Aging and exercise affect the level of protein acetylation and SIRT1 activity in cerebellum of male rats," Biogerontology, vol. 11, no. 6, pp. 679-686, 2010.
76. N. Braidy, G. J. Guillemin, H. Mansour, T. Chan-Ling, A. Poljak, and R. Grant, "Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats," PLoS ONE, vol. 6, no. 4, Article ID e19194, 2011.
77. D. Lee and A. L. Goldberg, "SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth," Journal of Biological Chemistry, vol. 288, no. 42, pp. 30515-30526, 2013.
78. S. Falone, A. D'Alessandro, A. Mirabilio et al., "Late-onset running biphasically improves redox balance, energy- and methylglyoxal-related status, as well as SIRT1 expression in mouse hippocampus," PLoS ONE, vol. 7, no. 10, Article ID e48334, 2012.
79. M. Sommer, N. Poliak, S. Upadhyay et al., "ΔNp63α overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse," Cell Cycle, vol. 5, no. 17, pp. 2005-2011, 2006.
80. M. Pallàs, J. G. Pizarro, J. Gutierrez-Cuesta et al., "Modulation of SIRT1 expression in different neurodegenerative models and human pathologies," Neuroscience, vol. 154, no. 4, pp. 1388-1397, 2008.
81. A. Coste, J. F. Louet, M. Lagouge et al., "The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α," Proceedings of the National Academy of Sciences of the United States of America, vol.105, no. 44, pp. 17187-17192, 2008.
82. Y. S. Hori, A. Kuno, R. Hosoda et al., "Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy," Journal of Pharmacology and Experimental Therapeutics, vol. 338, no. 3, pp. 784-794, 2011.
83. V. Ljubicic, M. Burt, J. A. Lunde, and B. J. Jasmin, "Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1a axis," The American Journal of Physiology - Cell Physiology, vol. 307, no. 1, pp. C66-C82, 2014.
84. M. W. McBurney, X. Yang, K. Jardine et al., "The mammalian SIR2α protein has a role in embryogenesis and gametogenesis,"Molecular and Cellular Biology, vol. 23, no. 1, pp. 38-54, 2003.
85. M. Coussens, J. G. Maresh, R. Yanagimachi, G. Maeda, and R. Allsopp, "Sirt1 deficiency attenuates spermatogenesis and germ cell function," PLoS ONE, vol. 3, no. 2, Article ID e1571, 2008.
86. H. Li, G. K. Rajendran, N. Liu, C. Ware, B. P. Rubin, and Y. Gu, "SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice," Breast Cancer Research, vol. 9, article R1, 2007.
87. L. Bordone, D. Cohen, A. Robinson et al., "SIRT1 transgenic mice show phenotypes resembling calorie restriction," Aging Cell, vol. 6, no. 6, pp. 759-767, 2007.
88. B. H. Ahn, H. S. Kim, S. Song et al., "A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14447-14452, 2008.
89. Y. Kawamura, Y. Uchijima, N. Horike et al., "Sirt3 protects in vitro - fertilized mouse preimplantation embryos against oxidative stress-induced p53-mediated developmental arrest," The Journal of Clinical Investigation, vol. 120, no. 8, pp. 2817-2828, 2010.
90. I. Manosalva and A. González, "Aging changes the chromatin configuration and histone methylation of mouse oocytes at germinal vesicle stage," Theriogenology, vol. 74, no. 9, pp. 1539-1547, 2010.
91. G. Di Emidio, S. Falone, M. Vitti et al., "SIRT1 signalling protects mouse oocytes against oxidative stress and is deregulated during aging," Human Reproduction, vol. 29, no. 9, pp. 2006-2017, 2014.
92. L.-L.Luo,X.-C.Chen,Y.-C.Fuetal.,"The effects of caloric restriction and a high-fat diet on ovarian lifespan and the expression of SIRT1 and SIRT6 proteins in rats," Aging Clinical and Experimental Research, vol. 24, no. 2, pp. 125-133, 2012.
93. X. M. Zhang, L. Li, J. J. Xu et al., "Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression,"Gene, vol. 523, no. 1, pp. 82-87, 2013.
94. N. Wang, L.-L. Luo, J.-J. Xu et al., "Obesity accelerates ovarian follicle development and follicle loss in rats," Metabolism: Clinical and Experimental, vol. 63, no. 1, pp. 94-103, 2014.
95. V. D. Kottarathil, M. A. Antony, I. R. Nair, and K. Pavithran, "Recent advances in granulosa cell tumor ovary: a review,"Indian Journal of Surgical Oncology, vol. 4, no. 1, pp. 37-47, 2013.
96. B. A. Benayoun, A. B. Georges, D. L'Hôtel et al., "Transcription factor FOXl2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase," Human Molecular Genetics, vol. 20, no. 9, pp. 1673-1686, 2011.
97. S. Pavlová, K. Klucska, D. Vašíček et al., "The involvement of SIRT1 and transcription factor NF-κB (p50/p65) in regulation of porcine ovarian cell function," Animal Reproduction Science, vol. 140, no. 3-4, pp. 180-188, 2013.
98. Y. Morita, O. Wada-Hiraike, T. Yano et al., "Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary," Reproductive Biology and Endocrinology, vol. 10, article14, 2012.
99. A. V. Sirotkin, P. Dekanová, A. H. Harrath, S. H. Alwasel, and D. Vašíček, "Interrelationships between sirtuin 1 and transcription factors p53 and NF-κB (p50/p65) in the control of ovarian cell apoptosis and proliferation," Cell and Tissue Research, vol. 358, no. 2, pp. 627-632, 2014.
100. C. Cantó, Z. Gerhart-Hines, J. N. Feige et al., "AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity," Nature, vol.458, no. 7241, pp. 1056-1060, 2009.
101. P. W. Caton, N. K. Nayuni, J. Kieswich, N. Q. Khan, M. M. Yaqoob, and R. Corder, "Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5," Journal of Endocrinology, vol. 205, no. 1, pp. 97-106, 2010.
102. M. Reverchon, M. Cornuau, L. Cloix et al., "Visfatin is expressed in human granulosa cells: regulation by metformin through AMPK/SIRT1 pathways and its role in steroidogenesis," Molecular Human Reproduction, vol. 19, no. 5, Article ID gat002, pp. 313-326, 2013.
103. D. B. Lombard, D. X. Tishkoff, and J. Bao, "Mitochondrial sir in the regulation of mitochondrial activity and metabolic adaptation," in Handbook of Experimental Pharmacology, vol. 206, pp. 163-188, 2011.
104. L. Pacella-Ince, D. L. Zander-Fox, and M. Lan, "Mitochondrial SIRT3 and its target glutamate dehydrogenase are altered in follicular cells of women with reduced ovarian reserve or advanced maternal age," Human Reproduction, vol. 29, no. 7, pp. 1490-1499, 2014.
105. H. Fu, O. Wada-Hiraike, M. Hirano et al., "SIRT3 positively regulates the expression of folliculogenesis- and luteinizationrelated genes and progesterone secretion by manipulating oxidative stress in human luteinized granulosa cells," Endocrinology, vol. 155, no. 8, pp. 3079-3087, 2014.
106. J.-C. Huang, L.-Y. Yan, Z.-L. Lei et al., "Changes in histone acetylation during postovulatory aging of mouse oocyte," Biology of Reproduction, vol. 77, no. 4, pp. 666-670, 2007.
107. Y.-Q. Su, K. Sugiura, Y. Woo et al., "Selective degradation of transcripts during meiotic maturation of mouse oocytes,"Developmental Biology, vol. 302, no. 1, pp. 104-117, 2007.
108. S. Takeo, D. Sato, K. Kimura et al., "Resveratrol improves the mitochondrial function and fertilization outcome of bovine oocytes," Journal of Reproduction and Development, vol. 60, no. 2, pp. 92-99, 2014.
109. R. H. Skoge, C. Dölle, and M. Ziegler, "Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels,"DNA Repair, vol. 23, pp. 33-38, 2014.
110. L. Zhang, X. Hou, R. Ma, K. Moley, T. Schedl, and Q. Wang, "Sirt2 functions in spindle organization and chromosome alignment in mouse oocyte meiosis," The FASEB Journal, vol. 28, no. 3, pp. 1435-1445, 2014.
111. F. C. H. Tsai and D. K. Gardner, "Nicotinamide, a component of complex culture media, inhibits mouse embryo development in vitro and reduces subsequent developmental potential after transfer," Fertility and Sterility, vol. 61, no. 2, pp. 376-382,1994.
112. S. S. Kwak, S. A. Cheong, J. D. Yoon, Y. Jeon, and S. H. Hyun, "Expression patterns of sirtuin genes in porcine preimplantation embryos and effects of sirtuin inhibitors on in vitro embryonic development after parthenogenetic activation and in vitro fertilization," Theriogenology, vol. 78, no. 7, pp. 1597-1610, 2012.
113. K. T. Howitz, K. J. Bitterman, H. Y. Cohen et al., "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan,"Nature, vol. 425, no. 6954, pp. 191-196, 2003.
114. B. P. Hubbard and D. A. Sinclair, "Small molecule SIRT1 activators for the treatment of aging and age-related diseases,"Trends in Pharmacological Sciences, vol. 35, no. 3, pp. 146-154, 2014.
115. J. A. Baur and D. A. Sinclair, "Therapeutic potential of resveratrol: the in vivo evidence," Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 493-506, 2006.
116. M. Liu, Y. Yin, X. Ye et al., "Resveratrol protects against age-associated infertility in mice," Human Reproduction, vol. 28, no. 3, pp. 707-717, 2013.